The Biosurgery Market Is Estimated To Witness High Growth Owing To...

The Biosurgery Market Is Estimated To Witness High Growth Owing To Growing Preference For Biosurgery Products Over Conventional Surgery Products

Сообщение 2023-12-01 10:30:28

1Кб

The Biosurgery market is estimated to be valued at US$15,870.09 Mn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Biosurgery involves the use of various human-derived or animal-derived natural biological materials as adjuncts or alternatives to synthetic surgical materials. Biosurgery products address wound healing, soft tissue repair/regeneration, bone grafting, and adhesion prevention or barrier application. These products are useful in reducing surgeons' reliance on sutures and staples and are absorbed into surrounding tissue after cell infiltration.

One of the key trends in the biosurgery market is the increasing number of surgical procedures across the globe. According to the National Center for Health Statistics, around 42 million in-patient surgeries and 49 million out-patient surgeries were performed in the US in 2020. Additionally, according to estimates by Frontiers of Surgery Organization, over 234 million surgeries are performed worldwide each year. This high number of surgeries has increased the demand for biosurgery products. Biosurgery products such as hemostats, sealants, and adhesion barriers are widely used during various surgical procedures to assist in hemostasis, prevent bleeding and adhesion formation, enhance wound healing, and act as a tissue bonding agent. Thus, rising surgical volumes are expected to propel the demand for biosurgery products over the forecast period.

The Global Biosurgery Market Size is expected to witness high growth, exhibiting CAGR of 6.9% over the forecast period, due to increasing chronic disease prevalence and trauma injury cases worldwide. Regionally, North America dominates the biosurgery market currently owing to established medical infrastructure and favorable reimbursement policies. Asia Pacific is anticipated to provide lucrative opportunities fueled by rising healthcare investments, unmet clinical needs and growing medical tourism.

http://digitalmarketinsights.weebly.com/blog/tissue-engineering-is-fastest-growing-segment-fueling-the-growth-of-biosurgery-market